| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 07/10/2008 | US20080167359 guanidines such as (1H-benzoimidazol-2-yl)(2,6-dichlorophenyl)methylamine, used as proton pump inhibitors for prevention or treatment of respiratory system, sleep, urogenital or nervous ststem disorders; as antihypotensive, neuroleptic, antidepressants, anxiolytic, antiischemic or antilipemic agents |
| 07/10/2008 | US20080167354 Treatment and/or prevention of disorders of fatty acid metabolism and glucose utilization and insulin resistance; 2-(hetero)aryloxazol-4-ylalkylcycloalkyl group, (2R/2S)-3-[(1R,3S)-3-(5-methyl-2-m-tolyloxazol-4-ylmethoxymethyl)-cyclohexyloxy ]-2-(4-trifluoromethylbenzyloxy)propionic acid |
| 07/10/2008 | US20080167352 3-(4-Chloro-phenyl)-adamantane-1-carboxylic acidisopropylamide; antiproliferative, antiinflammatory agent, angiogenesis inhibitor; sphingolipid-derived signaling pathway; coupling acid or acylhalide of phenyl-adamantane derivatives with aminoalkyl-pyridine |
| 07/10/2008 | US20080167346 low molecular weight factor Xa specific blood clotting inhibitors; less side effects; 5-Chloro-thiophene-2-carboxylic acid [2-(1-isopropyl-piperidin-4-ylsulfamoyl)-ethyl]-amide; thromboembolic diseases or restenosis; antithrombotic agents |
| 07/10/2008 | US20080167345 Amide substituted indazoles as poly(ADP-ribose)polymerase(PARP) inhibitors |
| 07/10/2008 | US20080167342 Heteroaryl-Substituted Amides Comprising An Unsaturated Or Cyclic Linker Group, And Their Use As Pharmaceuticals |
| 07/10/2008 | US20080167339 Hormone sensitive diseases; atherosclerosis; cardiovascular disorders; congestive heart failure; antidiabetic agents; metaboolism disorders; reducing triglycweride concentration |
| 07/10/2008 | US20080167334 Modulators of estrogen receptor alpha/beta G protein-coupled receptor 30, e.g., 1-(4-(6-Bromo-benzo[1,3]dioxol-5-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinolin-8-yl)1-ethanone; treating diseases such as cancer, neurodegenerative disorders, obesity, osteoporosis, and symptoms of menopause |
| 07/10/2008 | US20080167318 Pharmaceutically active pyrrolidine derivatives |
| 07/10/2008 | US20080167310 Syndrome X, antidiabetic agents; hypoglycemic agents;antilipemic agents; artherosclerosis; cardiovascular disorders |
| 07/10/2008 | US20080167307 Carboxylic Acid Derivative Containing Thiazole Ring and Pharmaceutical Use Thereof |
| 07/10/2008 | US20080167306 Novel Heteroaryl Derivative |
| 07/10/2008 | US20080167294 Cardiovascular disorders; liver disorders ; vascular system disorders; antiinflammatory agents; analgesics ; edema; hypotensive agents |
| 07/10/2008 | US20080167288 Substituted cyclic hydroxamates as lnhibitors of matrix metalloproteinases |
| 07/10/2008 | US20080167287 Imidazotriazines and imidazopyrimidines as kinase inhibitors |
| 07/10/2008 | US20080167280 Enhanced drug delivery in transdermal systems |
| 07/10/2008 | US20080167257 Therapy of acroparaesthsia, allergic (psoric) conditions, allergic reactions, alopecia, amnesia, anaphrodisia, angina, arthritis, asthenopia, biliary sycosis, burns, cancerous conditions, such as colon cancer, malignant melanoma and malignant nasal polyps, carpal tunnel syndrome, colds, conjunctivitis |
| 07/10/2008 | US20080167255 4-biarylyl-1-phenylazetidin-2-ones |
| 07/10/2008 | US20080167247 modulator of PKC V5 isozyme-specific peptide, or a modification, derivation, fragment, combination, or hybrid thereof; treatment of pain, cancer |
| 07/10/2008 | US20080167232 Anti-angiogenic and anti-tumor properties of vascostatin and other indogen domains |
| 07/10/2008 | US20080167227 biodrug laminin protein as angiogenesis inhibitors, antitumor agents; Inducing apoptosis in tissues; binding antibodies |
| 07/10/2008 | US20080167224 polypeptide with at least one amino acid replacement at position at 132, 134, 170, or 181; agonist of MET receptor; induce DNA synthesis, protect from liver damage from acetaminophen; gene therapy; promote cell growth angiogenesis, treatment of cardiovascular, hepatic, musculoskeletal, neuronal diseases |
| 07/10/2008 | US20080166768 Nucleic acid molecules encoding beta-like glycoprotein hormone polypeptide and heterodimer thereof |
| 07/10/2008 | US20080166730 Therapeutic and diagnostic proteins comprising a SOCS box |
| 07/10/2008 | US20080166724 VEGF-Modulated Genes and Methods Employing Them |
| 07/10/2008 | US20080166432 Biotherapeutics for Mitigation of Health Disorders from Terminalia Arjuna |
| 07/10/2008 | US20080166422 High unsaturated to saturated fatty acid ratio; reducing LDL cholesterol |
| 07/10/2008 | US20080166413 Topical pharmaceutical formulations and methods of treatment |
| 07/10/2008 | US20080166408 Oral Dosage Form Comprising Rosiglitazone |
| 07/10/2008 | US20080166389 Compositions and methods for treatment of hyperplasia |
| 07/10/2008 | US20080166387 Anti-angiogenic compositions and methods of use |
| 07/10/2008 | US20080166353 Using immunoglobulin specific to receptor for OX-2 membrane glycoprotein as diagnostic and therapeutic tool for treatment and prevention of asthma, infection, allergies, skin and cell proliferative disorders |
| 07/10/2008 | US20080166330 Bacterial Compositions For Prevention Or Treatment Of Atherosclerotic Disorders |
| 07/10/2008 | US20080166295 Administering an antibody that selectively binds to the extracellular region of human magic roundabout (MR); inhibiting angiogenesis |
| 07/10/2008 | DE202008005904U1 Kalt geknackte Cashewnuss zur Anwendung in der Therapie Cold cracked cashew nut for use in the therapy |
| 07/10/2008 | DE102007022161A1 neue Cyclohexenonverbindungen aus Antrodia camphorata und deren Anwendung cyclohexenone from Antrodia camphorata new and their application |
| 07/10/2008 | DE102007001370A1 RNA-kodierte Antikörper RNA-encoded antibody |
| 07/10/2008 | CA2674237A1 N-substituted-heterocycloalkyloxybenzamide compounds and methods of use |
| 07/10/2008 | CA2674154A1 Azaspiro derivatives |
| 07/10/2008 | CA2674133A1 Indoles |
| 07/10/2008 | CA2673584A1 Substituted oxindole derivatives and their use as vasopressin receptor ligands |
| 07/10/2008 | CA2670654A1 Cellular preparations for use as a revascularisation stimulating agent |
| 07/09/2008 | EP1942187A1 Cytokine protein family |
| 07/09/2008 | EP1942186A2 Recombinant platelet collagen receptor glycoprotein VI and its pharmaceutical use |
| 07/09/2008 | EP1942108A1 Compound containing basic group and use thereof |
| 07/09/2008 | EP1942104A1 Heteroarylcyclopropanecarboxamides and their use as pharmaceuticals |
| 07/09/2008 | EP1941908A1 Therapeutic agent for heart disease |
| 07/09/2008 | EP1941890A1 Hematopoietic stem cell proliferator |
| 07/09/2008 | EP1941879A1 Neuroprotective agent for the treatment of neuronal damage |
| 07/09/2008 | EP1941867A1 Prevention and reduction of blood loss |
| 07/09/2008 | EP1941829A2 Noninvasive measurement of chemical substances |
| 07/09/2008 | EP1940870A2 Conserved membrane activator of calcineurin (cmac), a novel therapeutic protein and target |
| 07/09/2008 | EP1940838A1 Triazolopyridine derivatives as inhibitors of lipases and phospholipases |
| 07/09/2008 | EP1940828A2 Heterocyclic aspartyl protease inhibitors |
| 07/09/2008 | EP1940811A1 Heterocyclic compounds with carboxyl isostere groups and their use for the treatment of cardiovascular diseases |
| 07/09/2008 | EP1940809A1 Tetrazol derivatives and their use for the treatment of cardiovascular diseases |
| 07/09/2008 | EP1940808A1 Difluorophenol derivatives and their use |
| 07/09/2008 | EP1940769A1 Dicarboxylic acid derivatives and their use |
| 07/09/2008 | EP1940768A1 Cyclopropylacetic acid derivatives and use thereof |
| 07/09/2008 | EP1940516A2 Benzopyran and pyranopyridine derivatives as potassium channel openers |
| 07/09/2008 | EP1940445A2 Stem cell derived factors for treating pathologic conditions |
| 07/09/2008 | EP1940409A1 Novel pharmaceutical combinations for the treatment of respiratory disorders |
| 07/09/2008 | EP1940402A2 Niacin receptor agonists, compositions containing such compounds and methods of treatment |
| 07/09/2008 | EP1940399A2 Use of par-i/par- 4 inhibitors for treating or preventing vascular diseases |
| 07/09/2008 | EP1940384A1 Process for the preparation of sour cherry seed extract, use of the extract for the preparation of pharmaceutical compositions and pharmaceutical compositions containing said extract |
| 07/09/2008 | EP1940378A1 Rxr agonists and antagonists, alone or in combination with ppar ligands, in the treatment of metabolic and cardiovascular diseases |
| 07/09/2008 | EP1940374A2 Combination of a renin-inhibitor and an anti-dyslipidemic agent and/or an antiobesity agent |
| 07/09/2008 | EP1819704B1 Pyrrolopyridine-2-carboxylic acid amide derivative useful as inhibitor of glycogen phosphorylase |
| 07/09/2008 | EP1653957B1 Piperidine compounds useful as malonyl-coa decarboxylase inhibitors |
| 07/09/2008 | EP1525188B1 Novel derivatives of 4,4'-dithiobis-(3-aminobutane-1-sulphonates) and compositions containing same |
| 07/09/2008 | EP1465863B1 Potassium channel modulators |
| 07/09/2008 | EP1385499B1 Use of carnitine for the preparation of an injection solution for preventing or alleviating ascites in poultry by in-ovo injection |
| 07/09/2008 | EP1338604B9 N-alkylglycine trimeres capable of protecting neurons against excitotoxic aggressions and compositions containing said trimeres |
| 07/09/2008 | EP1332133B1 Metabotropic glutamate receptor antagonists |
| 07/09/2008 | EP1303490B1 N-oxides as nk1 receptor antagonist prodrugs of 4-phenyl-pyridine derivatives |
| 07/09/2008 | EP1303304B1 Pharmaceutical combinations for treatment and prevention of diabetes mellitus |
| 07/09/2008 | EP1276729B1 New neurokinin antagonists for use as medicaments |
| 07/09/2008 | EP1234185B1 Pin1 as a marker of the stage of agressiveness and/or metastasis of abnormal cell growth |
| 07/09/2008 | EP1156820B1 Use of vascular endothelial growth factor-2 (vegf-2) |
| 07/09/2008 | EP1058680B1 2-arylethyl-(piperidin-4-ylmethyl)amine derivatives as muscarinic receptor antagonists |
| 07/09/2008 | CN101217953A Compounds having immunomodulator activity |
| 07/09/2008 | CN101217952A Composition for preventing occurrence of cardiovascular event |
| 07/09/2008 | CN101215283A Secalonic acid A compound and its preparing method and application in preparing neuron cell protection medicament |
| 07/09/2008 | CN101215258A Dihydropyridines calcium antagonist compounds, preparation method and medical use thereof |
| 07/09/2008 | CN101214344A Chinese medicine preparation for treating coronary disease and stenocardia and preparation thereof |
| 07/09/2008 | CN101214339A Hypertension-treating medicine and preparation thereof |
| 07/09/2008 | CN101214323A Orally-taken powder medicine and externally-applied plaster for treating angitis and preparation thereof |
| 07/09/2008 | CN101214314A Chinese medicine for treating cerebral apoplexy |
| 07/09/2008 | CN101214306A Chinese herbal medicine for treating high blood pressure |
| 07/09/2008 | CN101214305A Chinese medicine hemorrhoid suppository preparation method |
| 07/09/2008 | CN101214303A Application of í«damingí» capsule for treating diabetic cardiac disease |
| 07/09/2008 | CN101214296A Hypertension-treating medicine and preparation thereof |
| 07/09/2008 | CN101214281A Method for producing cistanche salsa extract |
| 07/09/2008 | CN101214279A Method for extracting flavone and polysaccharide from mulberry leaf |
| 07/09/2008 | CN101214277A Traditional Chinese medicine preparation for treating coronary disease and stenocardia and preparation thereof |
| 07/09/2008 | CN101214275A Compound red sage root extended release formulation and preparation thereof |
| 07/09/2008 | CN101214274A Detection method for active ingredient content in traditional Chinese medicine preparation í«xinkeningí» capsule |
| 07/09/2008 | CN101214271A Blumea balsamifera total flavones dispersible tablet and preparation thereof |
| 07/09/2008 | CN101214270A Acanthopanax senticosus effective fraction extract, preparation and application thereof |
| 07/09/2008 | CN101214269A Method for extracting and concentrating total flavones of ilex hainanensis |